Pharma Focus Asia
Klöckner Pentaplast - Pentapharm® alfoil® films

Drugs of Abuse Testing Market – Global Industry Analysis 2012 – 2016 and Opportunity Assessment 2017 – 2027

Market Overview:

•  Global Drugs of Abuse Testing market revenue is expected to increase at a CAGR of 6.1% during the forecast period (2017–2027)
•  In terms of revenue, Immunoassay was the dominant Drug type segment in the global drugs of abuse testing market in 2016. The segment is expected to further gain traction, owing to its functional benefits
     •  Hallucinogens segment is expected to register a CAGR of 5.7% during forecast period and is expected to gain significant market share by 2027 end
•  Forensic Laboratories segment market accounted for largest revenue market share of 36.3% in 2016. The segment is expected to register a CAGR of 5.8% during the forecast period.


•  Rise in Number of Clinical Laboratories offering Drugs of Abuse Testing Services
•  Rising Demand for Drug Abuse Testing from the Private Employers


•  Decrease in the Reimbursement Rates
•  Low Threshold of Drug Abuse Testing Laws in the Emerging and Under Developed Economies


•  Transition from Lab Based Screening to Disposable Devices
•  Growing Prescription of Drug Abuse Tests for Senior Citizens Seeking Pain Management Treatment by the Doctors

Overall Market Approach:

•  Companies focus on new launches and reducing the costs of drugs of abuse testing drugs in order to gain maximum market share
•  Acquisition, mergers, strategic collaborations, technology plays a vital role in the growth of global drugs of abuse testing market
•  Need to efficiently meet requirements of various types of treatment methods for various disease conditions, while ensuring supply of the required drugs abuse testing, as quality and positive outcome are of most importance to end useindustry.
•  Drugs of abuse testing is based on illicit drug supply and demand for drug tests globally. The increasing number of illicit drug users against number of tests conducted for screening drug abuse varies widely.

Target Drug Type:

•  Drugs are easily available, number of people using illicit drugs is very high in low-income countries. However the poor social structure, low awareness related to the effects of drug abuse and weak antidrug policies have failed to create the potential market for drug abuse testing service providers and product manufacturers.

Differentiating Strategy:

•  Manufacturers are focused on developing testing technique for better and quick result, thus expecting to increase their respective market shares
•  The companies are focusing on outsourcing the manufacturing of drug of abuse testing in order to reduce their manufacturing costs and thus competing in the market with reduced prices
•  Companies are entering into mergers and acquisitions to expand portfolio and market presence in global market


Source: Future Market Insights

magazine-slider-imageBIOVIA from Molecule to MedicineMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopCPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinRehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024